Search research articles
Contact Us
Filters
Showing results (151-160 of 179) with videos related to
Page
of 18
Sort By:
Lancet (London, England)
|
July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
Joe Y Chang, Steven H Lin, Wenli Dong, et al.
Cancer Cell
|
May 13, 2020
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer
Jian Carrot-Zhang, Nyasha Chambwe, Jeffrey S Damrauer, et al.
Clinical Lung Cancer
|
March 27, 2025
Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series
Xiuning Le, Anna Eisert, Te-Chun Hsia, et al.
Cancers
|
November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients
Morteza Salehjahromi, Hui Li, Eman Showkatian, et al.
Cancer Cell
|
October 8, 2019
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity
Jacqulyne P Robichaux, Yasir Y Elamin, R S K Vijayan, et al.
Cancer Cell
|
March 19, 2020
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity
Jacqulyne P Robichaux, Yasir Y Elamin, R S K Vijayan, et al.
JCO Precision Oncology
|
April 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity
Mitchell Parma, Kaiwen Wang, Ceylan Altintas Taslicay, et al.
Nature
|
September 16, 2021
Structure-based classification predicts drug response in EGFR-mutant NSCLC
Jacqulyne P Robichaux, Xiuning Le, R S K Vijayan, et al.
JTO Clinical and Research Reports
|
February 15, 2024
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From <i>EGFR</i>-Mutant NSCLC Informs Potential Therapeutic Targets
Bingnan Zhang, Whitney Lewis, C Allison Stewart, et al.
Cancers
|
December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Hui Li, Lingzhi Hong, Pedro Rocha, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 179) with videos related to
Sort By:
Page
of 18
Lancet (London, England)
|
July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
Joe Y Chang, Steven H Lin, Wenli Dong, et al.
Cancer Cell
|
May 13, 2020
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer
Jian Carrot-Zhang, Nyasha Chambwe, Jeffrey S Damrauer, et al.
Clinical Lung Cancer
|
March 27, 2025
Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series
Xiuning Le, Anna Eisert, Te-Chun Hsia, et al.
Cancers
|
November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients
Morteza Salehjahromi, Hui Li, Eman Showkatian, et al.
Cancer Cell
|
October 8, 2019
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity
Jacqulyne P Robichaux, Yasir Y Elamin, R S K Vijayan, et al.
Cancer Cell
|
March 19, 2020
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity
Jacqulyne P Robichaux, Yasir Y Elamin, R S K Vijayan, et al.
JCO Precision Oncology
|
April 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity
Mitchell Parma, Kaiwen Wang, Ceylan Altintas Taslicay, et al.
Nature
|
September 16, 2021
Structure-based classification predicts drug response in EGFR-mutant NSCLC
Jacqulyne P Robichaux, Xiuning Le, R S K Vijayan, et al.
JTO Clinical and Research Reports
|
February 15, 2024
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From <i>EGFR</i>-Mutant NSCLC Informs Potential Therapeutic Targets
Bingnan Zhang, Whitney Lewis, C Allison Stewart, et al.
Cancers
|
December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Hui Li, Lingzhi Hong, Pedro Rocha, et al.
Page
of 18